Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
Published in Future Oncology (Ahead of Print, 2025)
Related Articles
Pashtoon Kasi: New GI25 abstracts now released – OncoDaily
Pashtoon Kasi: New GI25 abstracts now released / ASCO GI25, cancer, OncoDaily, Oncology, Pashtoon Kasi
Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer – PubMed
In several malignancies, only a limited number of patients respond to immune checkpoint inhibitors. Predicting and monitoring responses to these inhibitors represent an unmet clinical…
Vinay Prasad’s Observations and Thoughts | Substack
Medicine, Oncology, Health Policy. Click to read Vinay Prasad’s Observations and Thoughts, a Substack publication with tens of thousands of subscribers.
Myeloma Paper of the Day, January 22nd, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, January 22nd, suggested by Robert Orlowski / cancer, Emily Tonorezos, Gina Tesauro, Jennifer Guida, Lisa Gallicchio, Michelle Doose,
Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy – PubMed
APP4 may be an easily accessible promising prognostic measure for patients with intermediate-risk prostate cancer treated with SBRT. Incorporation of APP4 into prospective trials will…
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Key PointsDNMT3Amt CH is associated with an age- and comorbidity-independent negative impact on COVID-19–related inflammatory outcomes and survival.The neg
A&E will be swamped by half of England’s population every year, warns top doctor
NHS national medical director Professor Sir Stephen Powis said the NHS ‘must go for broke’ to move care into communities if it wants to avoid…
Host Transition: Meet Cancer Stories New Host Dr. Mikkael Sekeres | ASCO Publications
We say thank you to current Cancer Stories host, Dr. Lidia Schapira, and welcome Cancer Stories new host, Dr. Mikkael Sekeres.
ExThera Claimed Its Device Could Cure Cancer. But Patients Died.
Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American regulators.